Showing results (1-10 of 280) with videos related to
Sort By:
Pageof 28
Journal of Psychopharmacology (Oxford, England)|June 23, 2016
Don't panic. A guide to tryptophan depletion with disorder-specific anxiety provocationS D Hood, C J Bell, S V Argyropoulos, et al.Expert Opinion on Investigational Drugs|November 4, 2000
Substance P antagonists: novel agents in the treatment of depressionS V Argyropoulos, D J NuttEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
The use of benzodiazepines in anxiety and other disordersS V Argyropoulos, D J NuttThe Psychiatric Clinics of North America|November 29, 2001
Brain function in social anxiety disorderS V Argyropoulos, C J Bell, D J NuttActa Neuropsychiatrica|March 18, 2016
The role of serotonin in panic: evidence from tryptophan depletion studiesA C Pyle, S V Argyropoulos, D J NuttPharmacology & Therapeutics|May 5, 2001
The psychobiology of anxiolytic drugs. Part 1: Basic neurobiologyJ J Sandford, S V Argyropoulos, D J NuttPharmacology & Therapeutics|May 5, 2001
The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxietyS V Argyropoulos, J J Sandford, D J NuttJournal of Psychopharmacology (Oxford, England)|October 8, 2008
Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressantsS D Hood, J P Potokar, S J C Davies, et al.Journal of Psychopharmacology (Oxford, England)|September 30, 2003
Does the brain noradrenaline network mediate the effects of the CO2 challenge?J E Bailey, S V Argyropoulos, S L Lightman, et al.The British Journal of Psychiatry : the Journal of Mental Science|June 4, 2002
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depressionJ A Hicks, S V Argyropoulos, A S Rich, et al.Pageof 28